Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alzheimer's disease
5
×
biogen
5
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
cancer immunotherapy
deals
medicare
pfizer
startups
abbvie
bristol-myers squibb
cancer
clinical trials
drug prices
eli lilly
What
bio
drug
5
×
roundup
alzheimer’s
biogen’s
companies
nash
news
price
prices
week
acquisitions
aducanumab
albert
amyloid
angst
annual
approval
assessed
attention
bagged
biggest
billions
biogen
biopharmaceutical
biotech
bourla
brammer
ceo
communities
company
conference
convo
crispr
different
earlier
effects
esmo
europe
fail
Language
unknown
Current search:
biogen
×
drug
×
" alzheimer's disease "
×
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More